Michael Ferguson
Corporate Officer/Principal chez ABIVAX
Postes actifs de Michael Ferguson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ABIVAX | Corporate Officer/Principal | 18/04/2023 | - |
Historique de carrière de Michael Ferguson
Anciens postes connus de Michael Ferguson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2019 | 01/05/2022 |
Formation de Michael Ferguson
| The Pennsylvania State University | Masters Business Admin |
| St. Joseph's University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| France | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABIVAX | Health Technology |
| Entreprise privées | 1 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Bourse
- Insiders
- Michael Ferguson
- Expérience
